All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
ARM / Arm Holdings plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
PRME / Prime Medicine, Inc.
|
|
|
|
|
|
|
|
FHTX / Foghorn Therapeutics Inc.
|
|
|
|
|
|
|
|
EXAS / Exact Sciences Corporation
|
|
|
|
|
|
|
|
VERV / Verve Therapeutics, Inc.
|
|
|
|
|
|
|
|
HLTH / Cue Health Inc.
|
|
|
|
|
|
|
|
PL / Planet Labs PBC
|
|
|
|
|
|
|
|
OSCR / Oscar Health, Inc.
|
|
|
|
|
|
|
|
BEAM / Beam Therapeutics Inc.
|
|
|
|
|
|
|
|
CRWD / CrowdStrike Holdings, Inc.
|
|
|
|
|
|
|
|
DXCM / DexCom, Inc.
|
|
|
|
|
|
|
|
DM / Desktop Metal, Inc.
|
|
|
|
|
|
|
|
QNCX / Quince Therapeutics, Inc.
|
|
|
|
|
|
|
|
BHIL / Benson Hill, Inc.
|
|
|
|
|
|
|
|
TEM / Tempus AI, Inc.
|
|
|
|
|
|
|
|
FULC / Fulcrum Therapeutics, Inc.
|
|
|
|
|
|
|
|
RGEN / Repligen Corporation
|
|
|
|
|
|
|
|
DNTH / Dianthus Therapeutics, Inc.
|
|
|
|
|
|
|
|
SPRO / Spero Therapeutics, Inc.
|
|
|
|
|
|
|
|
BRNS / Barinthus Biotherapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
MOND / Mondee Holdings, Inc.
|
|
|
|
|
|
|
|
RAPT / RAPT Therapeutics, Inc.
|
|
|
|
|
|
|
|
SANA / Sana Biotechnology, Inc.
|
|
|
|
|
|
|
|
ILMN / Illumina, Inc.
|
|
|
|
|
|
|
|
GLUE / Monte Rosa Therapeutics, Inc.
|
|
|
|
|
|
|
|
ALEC / Alector, Inc.
|
|
|
|
|
|
|
|
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
FRSH / Freshworks Inc.
|
|
|
|
|
|
|
|
GTLB / GitLab Inc.
|
|
|
|
|
|
|
|
TCRX / TScan Therapeutics, Inc.
|
|
|
|
|
|
|
|
HYPR / Hyperfine, Inc.
|
|
|
|
|
|
|
|
GUTS / Fractyl Health, Inc.
|
|
|
|
|
|
|
|
PATH / UiPath Inc.
|
|
|
|
|
|
|
|
LYEL / Lyell Immunopharma, Inc.
|
|
|
|
|
|
|
|
RVMD / Revolution Medicines, Inc.
|
|
|
|
|
|
|
|
TNYA / Tenaya Therapeutics, Inc.
|
|
|
|
|
|
|
|
KRON / Kronos Bio, Inc.
|
|
|
|
|
|
|
|
RLAY / Relay Therapeutics, Inc.
|
|
|
|
|
|
|
|
RANI / Rani Therapeutics Holdings, Inc.
|
|
|
|
|
|
|
|
DM / Desktop Metal, Inc.
|
|
|
|
|
|
|
|
NVTAQ / Invitae Corporation
|
|
|
|
|
|
|
|
VERA / Vera Therapeutics, Inc.
|
|
|
|
|
|
|
|
IVVD / Invivyd, Inc.
|
|
|
|
|
|
|
|
SNOW / Snowflake Inc.
|
|
|
|
|
|
|
|
TSHA / Taysha Gene Therapies, Inc.
|
|
|
|
|
|
|
|